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7/14 (50%) Gr III pts showed: 3 mild mitral stenosis, 2 TVT and 2 AVT.
AVT was also found in Gr I (2) and Gr II (1). PAPS pts had high incidence of
embolic sources: 11 % Gr I, 2B% Gr II and 63% Gr III (chi square = 6,95,
p < 0.05). Conclusions: 1) Multiplane TEE is useful to detect significative
valvular abnormalities and embolic sources in PAPS pts. 2) High levels (> 100
U) of aCL-a are associated to MVT and embolic sources, indicative of high
thromboembolic risk. 3) Follow-up studies are necessary to attribute to high
aCL-a levels a predictive value in PAPS pts.
Differences in Pulmonary Vein inertance: An
Explanation for Why Pulmonary Venous Flow is
not the Same in Each Vein
Randall Y. Grimes, Ajit P. Yoganathan, Robert A. Levine. Georgia Institute of
Technology, Affanta, GA; Massachusetts General Hospital, Boston, MA
Doppler of pulmonary venous (PV) flow have revealed that peak systolic flow
velocity is often different in each of the four PVs, In patients with mitral re-
gurgitation (MR). such differences have been ascribed to different relations
between the MR jet and PVs. However, anatomic studies also suggest that
the effective length of each PV tree may be different, creating differences in
the inertia of PV blood that must be accelerated by driving pressure gradients
between lungs and LA, both normally and with MR. Such inertance. which
varies with PV length. is a major determinant of pulsatile flow velocity, sug-
gesting the hypothesis that differences in PV inertia may cause or contribute
Fibrin strands (FS) shown by transesophageal echocardiography (TEE) on
the left heart valves have been associated with an increased risk of stroke
and systemic embolism. However, some have argued that FS merely rep-
resent degenerative valve changes due to stress or aging. The prevalence
of FS in patients with structurally normal or abnormal hearts is unknown,
To determine the prevalence of FS, we reviewed multiplane TEE from 100
patients. Group 1 consisted of 50 consecutive patients referred with various
diagnoses for TEE (23 M, 27 W, ages 18 to 79, mean 50 y). Group 2 consisted
of another 50 consecutive patients in sinus rhythm with structurally normal
hearts at TEE (28 M, 22 F, ages 17 to 76, mean 42 y), In Group 1. 3 of 20
patients (15%) evaluated for cardiac source of embolism showed FS, while
2 of 30 patients (7%) evaluated for other reasons showed FS. FS were seen
on the mitral valve in 3 patients and on the aortic valve in 2 patients. Three
(3) of the 5 valves with FS were structurally normal, while 2 were thickened.
In Group 2 (patients with normal hearts by TEE), 9 of 27 patients (33%) evalu-
ated for cardiac source of embolism showed FS, while only 1 of 23 patients
(4%) evaluated for other reasons showed FS. FS were seen on the mitral
valve in nine patients, while 1 patient had both mitral and aortic valve FS. Of
47 patients in both groups with a history of systemic embolism, 12 (25%)
had FS. Of the remaining 53 patients referred for other reasons, 3 16%) had
FS. (p < 0.01)
Conclusion: FS are frequently found at TEE in patients with a history of
systemic embolism-even in structurally normal hearts. FS are an infrequent
TEE finding in the absence of such a history.
Cardiac Involvement and Anticardiolipin
Antibodies Levels in Primary Antiphospholipid
Syndrome: A Transesophageal Study
Maurizio luriel, Edoardo Rossi, Cristina Crema, Anna Frisinghelli,
Sabrina Muzzupappa, Mariapia Serrago. Int Med II, asp .L. Sacco·, Univ Milan, Italy
Myocardial involvement and valvular lesions are frequently observed in Pri-
mary Antiphospholipid Syndrome (pAPS). particularly in patients (pts) with
clinical manifestations (arterial andlor venous thrombosis or recurrent fe-
tal loss). To evaluate whether high anticardiolipin antibodies (aCL-a) levels
are able to produce severe cardiac involvement or embolic sources (spon-
taneous echocontrast, masses or vegetations). we studied 30 PAPS pts (3
M and 27 F; aged 37 ± 10 yrs) by means of multiplane transesophageal
echocardiography (TEE). compared with 20-matched controls (C), We ana-
lyzed systo-diastolic LV function; abnormal leaflet thickness was >3 mm for
mitral or tricuspid valve (MVT or TVT) and >2 mm for aortic (AVT). aCL-a mea-
sured using standard ELISA method were expressed in GPL U, (normal value
<15 U), Results: All PAPS pts presented normal systo-diastolic LV function.
We considered 3 groups (Gr) according to aCL-a levels: Gr I (low-positive, 15-
35 U). mean MVT 2.7 ± 0.5 mm; Gr II (moderate-positive, 35-100 U). mean
MVT 3.4 ± O.B mm; Gr III (high-positive, > 100 U). mean MVT 3.5 ± 0.9 mm,
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Martin E. Goldman, Steven Goldstein, Itzhak Kronzon, Benico Barzilai,
Ravin Davidoff, Anthony DeMaria, Howard Dittrich, Shunichi Homma,
Michael Motro, Natesa Pandian, Michael Picard, Stacey Rosen, Steven Schwartz,
Paul A. Tunick, Zvi Vered, Gad Keren, David Vorchheimer, Larry Baruch, Oma David,
Jacqueline BUdd, Edward Fisher, VO,T.E. Study. Mt. Sinal: NY
Multiplane transesophageal echocardiography (MTEE) facilitates circumfer-
ential imaging while biplane (Bi) TEE has only 2 imaging planes and requires
more probe manipulation. To assess the clinical utmlity of the 2 types of TEE
probes, we analyzed TEE's of 3,182 pts enrolled in the Y:alue Qf lEI (V.OTE.)
multicenter study (12 different institutions). Probe selection was noncon-
trolled, determined by operator preference, Following completion of a TEE,
questions were posed to the referring physician on the immediate value of
the TEE regarding changes in clinical management (MNGL'l.) or drug regimen
(RxM, decision to perform surgery (SURGL'l.) or cardiac cath (CATHM. Diag-
nostic indication categories included: aortic dissection (AoD), stroke (CVAI
or TIA, congenital heart disease (CHD) and native valve (NAT V) or prosthesis
(Prosth) dysfunction.
Multiplane TEE was used more frequently in AoD, CHD & NAT V pts.less in
CVAJrIA pts. The complication (CaMP) rate, mean pt age and M/F ratio were
similar for both probes. Thus, in this noncontrolled study, multiplane TEE
had a greater immediate impact on clinical management decisions regarding
possible surgery and cath than did biplane.
Clinical Topics in Transesophageal
Echocardiography
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regurgitant volume, supporting the use of regurgitant orifice area as a more
fundamental gauge of the severity of MR.
Jonathan Lindner, Alex Case, John Dent, Duong Nguyen, Gregory Kauffman,
Sanjiv Kaul. University of Virginia, ChariottesvJ1le, Virginia
Although both transthoracic (TIE) and transesophageal (TEE) echo can de-
tect vegetations in patients with bacterial endocarditis (BE), their incremental
value over the available clinical information has not been examined. Accord-
ingly, we performed a prospective study in 105 patients (59 men, 46 women,
age range of 16-88 yrs) with suspected BE in whom TIE had been requested.
Thirty-four of these patients had known valvular disease, 19 had prosthetic
valves, and 53 had other sources of infection. In addition to TIE, TEE was
also performed in all patients. Twelve patients (11 %) had technically inad-
equate TIE, Predefined clinical variables were used to classify the patients
into low, medium, or high probability of haVing BE on clinical grounds. TIE
and TEE studies were read separately without any clinical information and
the patients were again classified into low, medium, or high probability of
BE based on the echo findings alone. Also, of the 67 patients with low clin-
ical probability of BE, the majority (79% by TIE and 87% by TEE) were also
considered to have low probability by echo; only 6% were considered high
probability. In patients with medium clinical probability of BE, the majority
(83% by TTE and 100% by TEE) were reclassified based on echo findings.
In patients with high clinical probability of BE, a significant portion 163% by
TTE and 50% by TEE) were also reclassified based on echo findings. There
was concordance between TTE and TEE in 86% of cases. The greatest dif-
ference was noted when TIE showed medium probability of BE: 8 of these
10 studies (80%) were reclassified based on TEE.
We conclude that in patients with low clinical probability of BE, echo offers
no incremental value, In patients with medium to high clinical probability of
BE, echo offers incremental value. In addition, TEE is indicated in the diag-
nostic work-up only in patients with technically inadequate TTE studies and
in those who show medium probability of BE after TTE; these constitute
<10% of patients with suspected BE in whom echo is requested.
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to clinically observed differences in PV flow. Methods: A mathematical model
of the atrium with two PVs was developed using an elastance model to de-
scribe pressure-volume relations. Using the unsteady Bernoulli equation in a
system of differential equations, an analytical solution of systolic PV flow in
each vein was achieved. Using the same conditions of initial atrial pressure
(10 mmHg) and relaxation, PV length was varied in one vein (5-15 cm). while
PV length remained constant (10 cm) in the other PV Results: As PV length in-
creased (more blood to be accelerated and greater inertia), peak systolic PV
flow decreased from 105 to 50 cmls in that vein, while peak flow increased in
the other from 55 to 70 cmls, even though its length was constant, reflecting
the reduced LA pressure response to less volume influx from the other pv.
Conclusions: PV inertance (length) is a major determinant of PV flow. As PV
inertia increases, peak systolic flow velocity decreases. PV flow in one vein
influences flow in another. Hence, differences in PV vein length and inertance
may be responsible for the differences in PV flow seen clinically in the same
atrium. and may also mimic or mask differences created by MR jets.
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1 1021-591 Influence of Cardiac Pacing Mode on Left Atrial
Appendage Function: Implication for the Cause
of Systemic Embolism in WI Pacing
ing warfarin had an event (p = 0.0009). Similarly when pts with and with-
out vascular events were compared, no differences in plaque dimensions
were found. In conclusion, mobile aortic plaque is associated with a high
frequency of vascular events during a relatively brief period of follow-up. Al-
though no morphologic aspect of the plaque predicts an event, it appears
that warfarin may provide adequate prophylaxis.
Clinical Studies in AMI
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Converting Enzyme Inhibition Decreases Infarct
Collagen and Limits Hypertrophy of Non-Infarct
Myocardium During Healing After Infarction
Bodh I. Jugdutt. University ofAlberta, Edmonton. Alberta, Canada
Inhibition of tissue angiotensin-converting-enzyme (ACE) activity can poten-
tially block both myocyte and fibroblast growth. The effects of 6 weeks of
ACE inhibition with enalapril (2.5 mg b.Ld.) and captopril (50 mg b.Ld.) on
in vivo changes in LV mass (two-dimensional echocardiography) and post-
mortem myocardial collagen content (hydroxyproline, mglg dry weight) were
measured during healing after anterior infarction (left anterior coronary artery
ligation) in 63 instrumented dogs (34 ACE inhibition: 29 placebo). Compared
to the placebo group. both ACE inhibitors prevented the increase in LV di-
astolic volume (+51 % versus -1.5%, p < 0.001) and LV mass (-3% versus
+ 13%, P < 0.005) over the 6 weeks. However, compared to placebo, ACE
inhibition decreased infarct collagen but not non-infarct collagen.
Hiroyuki Yoshitomi, Kazuaki Tanabe, Yo Murakami, Toshihlko Asanuma.
Hiromi Shimizu, Sachiko Yamada, Kazuya Sano. Toshio Shimada.
Shigefumi Morioka. Shimane Medical University. Izumo, Japan
A higher incidence of systemic embolism has been observed in patients with
WI pacing compared to DDD pacing. However. the cause of systemic em-
bolism in WI pacing remains unclear. Previous studies have demonstrated
that thrombus formation and systemic embolization are related to left atrial
appendage (LAA) dysfunction. To investigate the influence of pacing mode
on LAA function, we performed transesophageal echocardiography in 16 pa-
tients (mean age 65) with permanent DDD pacemakers. The indications for
pacemaker implantation were third degree atria-ventricular block (A-V block,
n = 10) and sick sinus syndrome (SSS, n = 6). All had shown sinus rhythm
at implantation. We measured peak LAA emptying and filling flow velocities
during both DDD and WI pacing at 60 beats/min. The data are summarized
below:
Infarct center
Normal zone
Captopril (23)
31 ± 2*t
5±0
Enalapril (II)
23 ± 5*
5±0
Placebo (29)
45 ± 3
5±0
Plaque Dimensions Vascular
Immobile Component Mobile Component Event
Height Width Area Height Width Area
WAR(n ~ 19) 7±3 29 ± 13 13 ± 6 8±9 3±3 5±8 0
NoWAR(n ~ 10) 6±2 30 ± 15 12 ± 8 7±4 3±2 2±3 6 (60%)
P NS NS NS NS NS NS 00009
Peak LAA flow velocities decreased significantly when a pacemaker was
reprogrammed from DDD to WI pacing mode. especially in patients with
SSS.
Conclusion: LAA function was impaired in WI pacing compared with that
in DDD pacing. These results suggest that impaired LAA function in WI pac-
ing may predispose the chamber to thrombus formation, which may playa
role in the mechanism of the embolization.
W.R. Craig, F.A. Dressler, L.M. Vaughn, D.E. Gamblin, A.J. Labovitz. Saint Louis
University Health Sciences Center
Although the mobile component of plaque is thought to represent thrombus,
the efficacy of anticoagulation has not been proven. In order to assess the
influence of anticoagulation in this population. we studied 29 pts with mobile
plaques found by TEE interrogation of the aortic arch. Each pt had had a
recent systemic embolism: cerebral in 27 (93%) and peripheral in 2 (7%).
After TEE, pt treatment was determined by physician preference. Follow-
up (mean 13 ± 12 mo.s) was obtained via telephone interview and chart
review. Of the 29 pts studied, 19 (66%) received warfarin (WAR) and 10 (34%)
received either aspirin (7) or no therapy(3). These groups were compared in
regards to dimensions of both mobile and immobile plaque components and
vascular events:
Mortality Results of the Trandolapril Cardiac
Evaluation (TRACE) Trial
*p < 0.001 vs. placebo. t p < 0.1. captopril vs. enalapril
Thus. both enalapril and captopril prevented LV dilatation and hypertrophy
during postinfarct healing. but enalapril decreased infarct collagen slightly
more than captopril. Differences in the effects of ACE inhibitors on myocyte
and fibroblast growth may explain some differences in their effects on postin-
farct remodeling, especially with large infarctions.
Lars K"ber, TRACE Study Group. TRACE study office, Copenhagen, Denmark
The aim of the TRAndolapril Cardiac Evaluation (TRACE) trial was to evaluate
whether mortality of patients with left ventricular (LV) dysfunction shortly
after myocardial infarction (Mil is reduced by long term treatment with an
ACE-inhibitor, regardless of the presence of heart failure or ischemia.
7001 consecutive enzyme confirmed Mis in 27 Danish hospitals were
screened for entry into the study 2-6 days following MI. At screening 2-
dimensional echocardiography was recorded on videotape at the center and
evaluated centrally. Wall motion index (WMI) was evaluated, and patients
with WMI :s 1.2 (corresponding to left ventricular ejection fraction :s 0.35)
were eligible for the study. Heart failure and ischemia did not exclude pa-
tients. After receiving a test dose. patients were randomly allocated to re-
ceive oral treatment with Trandolapril or placebo 3-7 days following the MI.
The primary endpoint was all cause mortality (intention to treat). Follow up
was a minimum of 2 years (range 2-4 years).
Results: 2606 (37%) of the screened Mis had WMI :s 1.2. This represented
a high risk group with an overalll-year mortality of 34%. In contrast, patients
with WMI > 1.2 had a one year mortality of only 12%. Of patients eligible for
the study based on LV function, 1749 patients (67%) were included.
876 patients received Trandolapril and 873 patients Placebo. Baseline char-
acteristics did not differ. Trandolapril caused a highly significant reduction in
overall mortality. Overall risk reduction was 22%, p = 0.0007. At study clo-
sure mortality of Trandolapril treated patients was 35% and that of placebo
treated patients 42%.
Conclusion: Long term treatment with Trandolapril of patients with LV dys-
function shortly after MI, significantly reduced mortality. The study adds to
the results of the SAVE trial by including a large proportion of eligible patients
and not excluding patients with heart failure or ischemia.
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The dimensions of both mobile and immobile components of plaque were
similar in the groups. Vascular events occurred in 6 (60%) of the No WAR
group (4 strokes and 2 myocardial infarctions) while none of the pts receiv-
